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Background: The 29 kDa Schistosoma haematobium species-specific antigen (ShSSA) is of remarkable interest in
the diagnosis of urinary schistosomiasis although it had not been fully characterized.
Method: To determine the biological importance of ShSSA in S. haematobium and pathogenesis of the disease, we
immunolocalized ShSSA in schistosome eggshells, miracidia and adult worm sections using indirect fluorescent
antibody test (IFAT).
Results: ShSSA was strongly immunolocalized in the schistosome eggshells, selective regions of the miracidia body
and walls of internal organs such as oviduct, ovary, vitelline duct and gut of the adult worm.
Conclusion: The strong immunolocalization of ShSSA in schistosome eggshells and adult worm internal organs
suggests that the antigens involved in the pathogenesis of urinary schistosomiasis could have originated from the
eggs and adult worms of the parasite.
The findings also indicate that ShSSA may play a mechanical protective role in the survival of the parasite.
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Schistosomiasis caused by trematode parasites of the
genus Schistosoma is still a very important waterborne
disease affecting humans today and yet considered as a
neglected tropical disease because of the misunderstand-
ing of the burden of the disease by policy makers. Schis-
tosome infection may cause severe pathology of the liver,
spleen, kidneys, bladder and urinogenital tract, and is re-
sponsible for high morbidity in endemic areas with an
estimated loss of 1.76 million DALYs [1].
Schistosome antigens are reported to be partly in-
volved in the pathology of schistosomiasis [2]. Several
schistosome antigens such as the variant forms of gluta-
thione S-transferase (P28/GST) and the 97 kDa paramyosin* Correspondence: eddenco@yahoo.com
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unless otherwise stated.(Sm97) have been studied with most of them derived from
S. mansoni and S. japonicum [3].
Characterization of schistosome antigens identified by
monoclonal antibodies (MoAbs) could enhance schisto-
somiasis control for two main reasons. Firstly, such anti-
gens may carry specific epitopes serving as targets for
immune attack and are therefore potential candidates
for vaccine production [4,5]. Secondly, where the anti-
gen has diagnostic potential, it may be explored to im-
prove diagnosis and provide useful information on
evolution and classification of schistosomes. Identifica-
tion and characterization of more schistosome antigens,
especially from S. haematobium are therefore necessary
for improving diagnosis and treatment outcomes.
A 29 kDaS. haematobium species-specific antigen
(ShSSA) was identified in both Ghanaian and Egyptian
strains of the parasite [6,7]. Even though a monoclonal
antibody (MAb) to ShSSA has been successfully used in
a field applicable dipstick for diagnosis of urinary schis-
tosomiasis [8,9] ShSSA has not been fully characterized.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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morphological and ultrastructural levels in S. haemato-
bium will provide answers to critical questions about
the use of the antigen in estimating infection intensity.
Furthermore, immunolocalization of the antigen will
provide data on its role in the survival of the parasite
and significance in its taxonomy [10]. A major objective
of this study, therefore, was to immunolocalize ShSSA
in all life-cycle stages of S. haematobium. In addition,
in order to ascertain the suitability of infected urine
samples and parasite eggs for immunolocalization stud-
ies on ShSSA, this study was conducted with a view to
determine the reactivity of MAb to crude antigens from
eggs and urine of study subjects. Finally, to identify
urine samples that can provide adequate amount of
parasite eggs for generation of S. haematobium life-
cycle stages and crude antigen extracts, this study was
conducted to determine the sensitivity and specificity of
microscopy or MAb dipstick test at detecting parasite
eggs or antigens from the urine of study subjects.
Methods
Study design and population
The study was a purposive cross sectional study involv-
ing elementary school pupils who answered yes to whether
or not they have any of the signs and symptoms of urinary
schistosomiasis.
The S. haematobium species-specific MAb required
for detection of the 29 kDa antigen was purified and the
reactivity confirmed. Active MAb fractions were utilized
for the urinary schistosomiasis MAb dipstick assay
(USDA), microplate enzyme-linked immunosorbent assay
(ELISA) and indirect fluorescent antibody test (IFAT).
Urine samples for the study were collected from a total
of 292 elementary school pupils from two villages,
Kwashikumahman (n = 190) and Kojo Ashong (n = 102),
hyperendemic for urinary schistosomiasis [11]. Aliquots
of urine samples from subjects showing urinary schisto-
somiasis symptoms, haematuria and dysuria, were tested
for S. haematobium antigens and eggs using USDA and
microscopy respectively. Schistosome eggs were isolated
from urine samples with >100 eggs/10 ml of urine for
soluble egg antigen preparation, generation of parasite
stages and for immunolocalization.
Study area
The study was conducted at Kojo Ashong and
Kwashikumahman in the Greater Accra Region of
Ghana. These villages are located on 5°43'N, 0°23.5'E and
5°43'N, 0°21.5'E, respectively. The vegetation along the
banks of the slow flowing Densu River and Dobro stream,
running at the outskirts of the villages, comprises mainly
grassland and a few trees. The weedy river and stream
banks contain decomposing plant leaves and twigsinfested with urinary schistosomiasis vector snails, Bulinus
globosus. The Densu River and the Dobro stream consti-
tute the principal sources of water for domestic use and
transmission of urinary schistosomiasis.
Ethical consideration
Study subjects were elementary school pupils assigned
by the Ghana Health Service, Ministry of Education and
Noguchi Memorial Institute for Medical Research for
schistosomiasis examination and treatment. Subjects
were recruited if they discharged urine with blood and/
or pain. Informed consent was obtained from Education
Authorities and parents and/or guardians of pupils be-
fore recruitment. Infected children were treated with
40mg/kg body weight of praziquantel (Merck KGaA,
Darmstadt, Germany) as recommended by WHO [12]. Ap-
proval for this study was given by the Noguchi Memorial
Institute for Medical Research Institutional Review Board,
referenced NMIMR-IRB CPN 042/06-07 rev 2008.
Collection and analysis of urine specimens
Field procedures
Collection and handling of urine samples Twenty to
100ml of fresh clean catch urine was collected from each
of 292 school pupils in the period between 11:00 and
14.00hours Greenwich Mean Time (GMT) into a 200ml
urine container. The samples were then transported to
the laboratory at the Noguchi Memorial Institute for
Medical Research within 1hour on ice in ice-chest.
Laboratory procedures
Examination of urine samples for parasite antigens and eggs
Within 3hours after arrival at the laboratory urine sam-
ples were tested individually for S. haematobium antigen
by MAb dipstick as described elsewhere [8,9,11]. Also,
10ml of the urine was filtered through a 25mm Nucleo-
pore filter (12μm pore size) [11] to determine parasite
density. The rest of the urine was centrifuged at 1,290 X g
to isolate S. haematobium eggs.
Generation of S. haematobium parasite life-cycle stages
S. haematobium eggs were isolated by centrifugation
and sedimentation as described by Bosompem and
others [13] and then cleaned by density centrifugation
through ficoll-paque™ (GE Healthcare Life Sciences,
Buckinghamshire, UK). They were subsequently hatched
into miracidia by exposure to clean aged tap water and
light as described by Huyse and others [14]. Some of the
miracidia were used to infect Bulinus snails (five mira-
cidia/ snail) to generate cercariae as described elsewhere
[15,16]. Some of the live cercariae were transformed
into schostosomula by vortexing (Ikemoto Rikakogyo Co.
Ltd., Japan) as described by Ramalho-Pinto and others
[17] for 20min. Some cercariae were also used to infect
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the eggs, miracidia, cercariae, schistosomula and adult
worms were respectively homogenized by sonication [15]
to prepare crude antigens or treated with fixatives for
immunolocalization studies.
S. haematobium parasite stages and fixatives for
immunolocalization
S. haematobium parasite stages were fixed for immuno-
localization according to the method described else-
where [18] with modification.
Washed S. haematobium eggshells, miracidia, cercariae,
schistosomula and adult worms were suspended in PBS
containing different concentrations of fixatives namely,
paraformaldehyde, glutaraldehyde, Karnovsky’s fixative,
methanol, ethanol and acetone, and incubated at 4°C for 5
min, 30 min, 60 min, 90 min and overnight (12 hrs). The
concentrations of the various fixatives tested were, 0.1,
0.25, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 10 and 100%. Fixed
specimens were washed four times with PBS by centri-
fugation at 16,000 xg for 10 min at 4°C, stored in PBS at
4°C and analyzed by a preliminary IFAT to determine
and select the best fixatives and conditions for immuno-
localization studies.
Preparation of S. haematobium adult worms for (IFAT)
Adult worms were prepared for IFAT as described else-
where [19-21] with modification. Fixed S. haematobium
adult worms were incubated for 5mins in saturated picric
acid to colour the specimen and enhance visualization.
The worms were dehydrated stepwise by transferring
them into ethanol (85% for 10 min, 95, 100 and 100%,
each for 20 min) and then 100% chloroform (3 times, each
for 10 min). The worms were transferred into molten par-
affin wax at 56°C (2 times for 10 min each) to fill open
cavities with wax, embedded in wax and then cut into 4 μmTable 1 Reactivity of purified MAb.F fractions with crude anti
human urine
Antibody fraction Crude antigens
Egg lysate P2J* M
Amicon concentrated 2+ 3+ >
Ion-exchange purified 2+ 2+ +
Precipitated by 50% (NH)2SO4 solution 3+ 2+ >
Immunized mouse serumα 3+ 3+ >
Normal mouse serumβ - - -
Antibody-free culture mediumω - - -
*Crude antigens extracted from S. haematobium infected human urine.
α Positive control sample.
β Negative control sample.
ω Background blank sample.
+ Positive reaction.
- Negative reaction.
> + Stronger than positive, but weaker than 2+.
<+ Weak reaction or trace.sections with a microtome (Yamato Koki Individuals. Co.,
Ltd., Tokyo, Japan.). Worm sections on glass micro-
scope slides were deparaffinized by heating at 50°C for
2 hr and then washed twice in xylene (5 min/wash). The
worms were then re-hydrated stepwise in 100, 100, 95
and 90% ethanol (5 min/step). Finally, the worm sec-
tions were rinsed, 5 min each, under running distilled
water and in PBS.
Monoclonal antibody (MAb)
The IgG1MAb used in this study was generated by im-
munizing BALB/c mice with antigens extracted from S.
haematobium infected human urine [6,7]. This antibody
did not cross-react with Necator americanus (hook-
worm) egg antigens in micro-plate ELISA, and could bind
ShSSA, from the eggs of both Ghanaian and Egyptian
strains of S. haematobium and infected human urine
[6-8]. The antibody in culture supernatant was concen-
trated ten-fold by Amicon filtration or by precipitation
with 50% (v/v) ammonium sulphate [(NH4)2SO4] and then
purified by ion-exchange chromatography. Microplate
ELISA was used to determine the reactivity of this MAb
to ShSSA in infected human urine and homogenates of
parasite stages as described earlier [6].
IFAT procedure
IFAT was conducted on the prepared parasite stages as
described elsewhere [19,22] with modification. Fixed
eggshells, miracidia, cercariae and schistosomula in sus-
pension were coated, 20–30 specimens/well, onto multi-
well IFA slides by heating briefly over a Bunsen flame.
Slides coated with worm sections or other parasite stages
were immersed briefly in a destaining jar containing 0.2 M
Phosphate Buffered Saline (PBS, pH 7.2) to wash off
loosely bound materials. Excess PBS was blotted by touch-
ing the edge of the slides with filter paper after whichgens fromS. haematobium parasite stages and infected
iraci-dium Cercaria Schistoso-mulum Adult worm
+ + <+ >+
+ <+ +
+ + <+ >+
+ + <+ >+
- - -
- - -
Table 2 Prevalence of urinary schistosomiasis in the study communities as determined by microscopy and dipstick
assay
Community Number tested Microscopy+ve (%) Dipstick+ve (%) *Sensitivity(%) *Specificity (%)
K A 102 30 (29.41) 42 (41.18) 100 75.00
K M 190 98 (51.58) 121 (63.68) 100 83.33
Total 292 128 (43.84) 163 (55.82) 100 78.66
K A Kojo Ashong.
K M Kwashikumahman.
*Relative sensitivity and specificity based on microscopy as gold standard test.
Table 3 a & b: evaluation of different fixatives for processing S. haematobium (Sh) parasite stages for immunolocalization (IL)
Table 3a
Type of fixative Duration of treatment of Sh parasite stages Concentration of fixative
0.10 0.25 0.50 1.00 1.50 2.00
Karnovsky’s fixative 90 min + (+) 3+ (±)
12 hr + (+) 2+ (±)
Paraform-aldehyde 90 min
12 hr
Glutar-aldehyde 90 min 3 + (2+) 3 + (2+) 2 + (2+) + (±)
12 hr 3 + (2+) 2 + (2+) 2 + (2+) ± (±)
Methanol 90 min + (±) ± (±)
12 hr + (±) ± (±)
Ethanol 90 min ± (±) + (±)
12 hr + (±) ± (±)
Acetone 5 min
90 min 2+ (−) 2+ (−)
12 hr 2+ (−) 2+ (−)
Table 3b
Type of fixative Duration of treatment of Sh parasite stages Concentration of fixative
2.50 3.00 4.00 5.00 10.00 100.00
Karnovsky’s fixative 90 min + (+)
12 hr + (+)
Paraform-aldehyde 90 min ± (−) ± (−)
12 hr + (−) + (−)
Glutar-aldehyde 90 min + (±) ± (±)





Acetone 5 min 2+ (−)
90 min
12 hr
Results in parenthesis, ( ), indicate the intensity of background staining.
± Indicates weak fluorescence.
Blank spaces on the table represent negative fluorescence and background staining results. Except for 100% acetone which gave positive fluorescence at 5 min of
fixation, all the reagents at all the concentrations gave negative fluorescence and background staining at 5, 30 and 60 min of fixation, and were not represented
on the table.
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(immune) sera or negative control (free medium) at
20 μl/well for 1 hr at room temperature. Primary anti-
bodies, Sh2/15.F and immune sera were used at 1:40
and 1:50 dilution, respectively. The slides were washed
twice (5mins per wash) with PBS and then incubated for
30 min (20 μl/well) with secondary antibody reagent
[goat-anti-mouse IgG conjugated with fluorescein iso-
thiocyanate (FITC) (Sigma Immuno Chemicals, St. Louis,
MO) and 0.01% trypan blue (counter stain), all in PBS].
After incubation the slides were washed four times in PBS,
blotted and then mounted in 50% glycerol (Sigma-Aldrich
Co. Ltd.-Gillingham-Dorset, UK) in PBS. The specimens
were observed using a flourescent microscope (Olympus
Optical Co. Ltd., Japan) at x120 magnification.
Results
Reactivity of purified MAb fractions
Table 1 summarizes the reactivity of different fractions
of MAb to crude antigens from S. haematobium parasite
stages and infected human urine as determined by
micro-plate ELISA. The results show that MAb was re-
active to crude antigens from all life-cycle stages of the
parasite and infected human urine.
Prevalence of Urinary Schistosomiasis
Table 2, summarizes urinary schistosomiasis prevalence
both at Kojo Ashong and Kwashikumaman as deter-
mined by microscopy and MAb-dipstick, USDA. Of the
292 individuals interviewed verbally for the presence or
absence of urinary schistosomiasis, 58.56% (171/292)
answered yes. Also, USDA detected S. haematobium
antigens in more (55.82%) of the 292 subjects than mi-
croscopy (p < 0.01). The analysis showed that the urinary
schistosomiasis prevalence estimated by microscopy in
Kwashikumaman (51.58%) (98/190) was higher (p < 0.01)
than that of Kojo Ashong (29.41%) (30/102). A similarFigure 1 Immunolocalization of the 29 kDa antigen in S. haematobium egg sh
eggshells under x120 magnification, showing strong fluorescence (immunoloc
following incubation with MAb and anti-mouse-FITC conjugate antibody. (A) U
haematobium species-specific (diagnostic) antigen.trend was found using the USDA (p < 0.01). All individ-
uals who were S. haematobium egg positive also tested
positive for parasite antigens by the USDA.
Evaluation and selection of fixatives for immunolocalization
Table 3 summarizes the results of the experiment to de-
termine the suitability of six fixatives (paraformaldehyde,
glutaraldehyde, Karnovsky’s fixative, acetone, methanol
and ethanol) for processing S. haematobium parasite stages
for immunolocalization. As shown, 2.0% Karnovsky’s
fixative (2% paraformaldehyde plus 2% glutaraldehyde)
applied for 90 min at 4°C, produced the highest positive
fluorescence with a weak background staining as com-
pared to the other fixatives. Consequently, this fixative
at the application conditions was used to process the spec-
imens for immunolocalization of the diagnostic antigen.
Immunolocalization of the 29 kDa S. haematobium antigen
using IFAT
The 29 kDa S. haematobium diagnostic antigen,
ShSSA, was immunolocalized to the scleroproteic egg-
shell (Figure 1). However, the inner wall of the eggshell
(vitelline membrane) showed more intense fluorescence in
some specimens. As shown in Figure 2, the antigen was
also immunolocalized mostly to the cilia and patches on
the dorsal surface of the tegument of the miracidia. In
the adult worm, ShSSA was immunolocalized in the en-
tire section. However, the antigen appeared to be con-
centrated in the inner lining of internal organs such as
the ovary and gut (Figure 3).
Discussion
The aim of this study was to immunolocalize the 29 kDa
Schistosoma haematobium species-specific antigen (ShSSA)
in all the life-cycle stages of the parasite. Even though a
monoclonal antibody (Sh2/15.F) against this antigen has
enabled it to be identified in a field-applicable dipstick testell by immunofluorescence. (A) and (B) are micrographs of S. haematobium
alization of ShSSA*) in the outer membrane and inner lining of the shells
nder ordinary light (B) under fluorescent light (*) 29 kDa Schistosoma
Figure 2 Immunolocalization of the 29 kDa antigen in S. haematobium
miracidia by immunofluorescence. Figure is a micrograph of S.
haematobium miracidia, under x120 magnification, showing
immunolocalization of ShSSA in selective regions of the body,
following incubation with Sh2/15.F MAb and anti-mouse-FITC
conjugate antibody. U) Tail, V) Basal regions of lateral sides of the
body trunk, W) Cilia, X) Patches on the dorsal surface of the tegument,
Y) Anterior region of the body.
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ShSSA has not been fully studied. Immunolocalization
of ShSSA at the morphological and ultrastructural levels
in the parasite, therefore, is of paramount importance to
provide answers to critical questions about the relative
abundance of the antigen in the parasite stages and its
applicability in estimating infection intensity. Also, im-
munolocalization studies on this antigen will provide
data on the possible role of ShSSA in the survival of the
parasite. Lastly, immunolocalization of this antigen will
provide information on the stage of the parasite life-
cycle to concentrate efforts on for studies on this anti-
gen. To achieve this aim, therefore, we isolated parasite
eggs from the urine of infected school-aged children
from which we generated the various life-cycle stages of
the parasite [6,13-17]. Immunofluorescence assay was
then used to localize the 29 kDa Species-specific antigen
in the various life-cycle stages of the parasite [18-22].Figure 3 Immunolocalization of the 29 kDa antigen in S. haematobium adult
of cross-sections from two different S. haematobium adult worms under x120
of various internal organs such as oviduct, ovary, vitelline duct and diges
Sh2/15.F MAb and anti-mouse-FITC conjugate antibody.From this study, the 29 kDa antigen (ShSSA) was de-
tected in all the life-cycle stages of S. haematobium and
in the urine of infected individuals. To our knowledge,
this is the first study to immunolocalize a species-
specific potential diagnostic marker antigen in the vari-
ous life-cycle stages of the S. haematobium parasite.
Immunolocalization of proteins provides answers to
critical questions concerning the roles of specific anti-
gens in classification and survival of parasites [10]. For
example, immunolocalization studies confirmed para-
myosin as a muscle protein and contributed to the
understanding of its multiple functions within the schis-
tosome [10]. In this study, the ShSSA present in both
Ghanaian and Egyptian strains of S. haematobium [7]
was immunolocalized in the eggshells, miracidia and
adult worm. This observation coupled with the detec-
tion of ShSSA in homogenates of S. haematobium adult
worm, eggs, miracidia, cercariae and schistosomula by
microplate ELISA and USDA, indicated that ShSSA may
be distributed in all the life-cycle stages of the parasite.
Also, the identification of ShSSA in strains of the para-
site from Egypt and different regions of Ghana [7-9]
suggested that this antigen has a wide geographic distri-
bution. In addition the wide distribution of this antigen
in S. haematobium both stage-wise and geographically vis-
a-vis its absence in S. mansoni and N. americanus [7-9],
emphasizes its possible specificity to S. haematobium and
potential usefulness in taxonomic classification of the
parasite and diagnosis of urinary schistosomiasis.
Labelling of ShSSA in the eggshells and miracidia con-
firmed the presence of the antigen in the S. haematobium
eggs. The S. haematobium eggshell is scleroproteic and
has sub-microscopic pores through which antigens are
excreted [23-27]. It is therefore, possible that the antigen
immunolocalized is a structural component of the egg-
shell, had diffused from the miracidia into the shell, or
both.
In addition, the immunolocalization of ShSSA in the
eggshell, tegument and cilia of miracidia and walls ofworm cross-sections by immunofluorescence. (A) and (B) are micrographs
magnification showing strong immunolocalization of ShSSA in the walls
tive caeca, labelled U, V, W, X, Y and Z, following incubation with
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the adult worm, suggests that, possibly, this protein has
a muscular function in the parasite. Further studies are
however required to ascertain this observation. Further-
more, the localization of ShSSA in both eggs and adult
worms of S. haematobium suggests that the antigen de-
tected in infected persons may originate from both
stages of the parasite, since these are the stages found in
humans. Hence, it may be difficult but interesting to use
measured antigen levels to estimate egg or worm burden.
High relative sensitivity (99.1%) and specificity (98.3%)
were reported for USDA in earlier studies [11], however,
in this work, the specificity (78.66%) of the MAb-
dipstick compared to microscopy as a gold standard test
was significantly lower (p < 0.01) whilst the sensitivities
were the same (100%). The rather low relative specificity
recorded by USDA in this study could be attributable to
either a low sensitivity of the microscopic technique or
high false positivity rate of the USDA. The first explan-
ation is more likely to be correct because, Bosompem
et al. [11] re-examined urine samples with low egg
counts, which readily tested positive by USDA, seven
times more before confirming their positivity by mi-
croscopy. The higher (p < 0.01) prevalence of urinary
schistosomiasis obtained by USDA compared to mi-
croscopy was therefore not surprising. One limitation
of this study is the inability to repeat testing of the sam-
ples to ascertain parasite infectivity rates.
Conclusions
In conclusion, this study has confirmed the suitability of
the USDA for detecting S. haematobium infections in
humans. The 29 kDa antigen was found in all the life-
cycle stages of S. haematobium and in the urine of in-
fected individuals. The 2% Karnovsky’s fixative was
shown to be suitable for immunolocalization studies on
ShSSA. The presence of ShSSA in both eggs and adult
worms of S. haematobium suggests that the antigen
detected in infected persons may originate from both
stages of the parasite.
Recommendations
It is recommended that further immunolocalization stud-
ies be conducted on the 29 kDa S. haematobium species-
specific antigen at the ultrastructural level by electron
microscopy to elucidate the function(s) of this diagnostic
antigen in the various stages of S. haematobium.
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